Sector consensus Vertex Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 02/07/2026 BST			5-day change	1st Jan Change
528.04 ^USD	+6.03%		+7.47%	+16.47%

07-02	Vertex Pharmaceuticals Incorporated Receives Us Fda Approval for Expanded Use of Casgevy for Treatment of People Ages 2 Years and Older with Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia	CI
07-02	Vertex Pharmaceuticals Says FDA Approves Expanded Use of Casgevy in Younger Children With Blood Disorders	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
VERTEX PHARMACEUTICALS INCORPORATED	548.69	+3.91%	29
ELI LILLY AND COMPANY	1,220.39	+0.53%	28
JOHNSON & JOHNSON	257.5	-2.11%	22
ABBVIE INC.	256.14	-1.89%	28
ROCHE HOLDING AG	358.94	+5.39%	18
ASTRAZENECA PLC	217.82	+12.83%	22
NOVARTIS AG	154.03	-3.26%	21
NOVO NORDISK A/S	315.66	-3.44%	24
AMGEN INC.	354.76	-5.18%	29
GILEAD SCIENCES, INC.	157.67	+20.11%	27
PFIZER INC.	29.15	+19.86%	27
GSK PLC	20.95	+3.99%	19
SANOFI	96.7	+27.56%	23
CHUGAI PHARMACEUTICAL CO., LTD.	10,006.67	+30.94%	15
BAYER AG	52.47	-1.66%	18
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	81.14	+49.02%	16
TAKEDA PHARMACEUTICAL COMPANY LIMITED	6,106.87	+13.96%	15
HALEON PLC	4.142	+13.71%	17
ALNYLAM PHARMACEUTICALS, INC.	434.72	+38.99%	25
Average	1,088.13	+11.75%	22
Weighted average by Cap.	714.32	+4.22%	24